Efficacy of Glucocorticoid plus Intravenous Immunoglobulin in Children with Immunoglobulin-Insensitive Kawasaki Disease.
Journal
Journal of healthcare engineering
ISSN: 2040-2309
Titre abrégé: J Healthc Eng
Pays: England
ID NLM: 101528166
Informations de publication
Date de publication:
2022
2022
Historique:
received:
04
03
2022
accepted:
24
03
2022
entrez:
25
4
2022
pubmed:
26
4
2022
medline:
27
4
2022
Statut:
epublish
Résumé
This study mainly analyzes the clinical effect of glucocorticoid (GC) plus intravenous immunoglobulin (IVIG) in treating children with immunoglobulin (Ig)-insensitive Kawasaki disease (KD). From September 2013 to November 2021, 86 Ig-insensitive KD children were selected, including 46 children (observation group, Obs) treated with GC plus IVIG, and 40 children (control group, Con) treated with IVIG. The symptom (fever and fever) resolution time, inflammatory factors (C-reactive protein, CRP; procalcitonin, PCT; interleukin-6, IL-6), immune indicators (CD3
Identifiants
pubmed: 35463656
doi: 10.1155/2022/9011259
pmc: PMC9020913
doi:
Substances chimiques
Glucocorticoids
0
Immunoglobulins, Intravenous
0
Interleukin-6
0
Types de publication
Journal Article
Retracted Publication
Langues
eng
Sous-ensembles de citation
IM
Pagination
9011259Commentaires et corrections
Type : RetractionIn
Informations de copyright
Copyright © 2022 Yongmei Ma et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
J Immunol. 2018 Mar 15;200(6):1957-1963
pubmed: 29507120
Eur J Pediatr. 2021 Mar;180(3):717-723
pubmed: 32772155
N Engl J Med. 2012 Nov 22;367(21):2015-25
pubmed: 23171098
Phytomedicine. 2020 Apr 15;70:153208
pubmed: 32283413
Turk Kardiyol Dern Ars. 2010 Jan;38(1):20-4
pubmed: 20215838
J Zoo Wildl Med. 2021 Jan;51(4):926-932
pubmed: 33480573
Arch Immunol Ther Exp (Warsz). 2017 Jun;65(3):215-231
pubmed: 27638480
J Pediatr. 2003 Sep;143(3):363-7
pubmed: 14517521
Eur Rev Med Pharmacol Sci. 2016 Jun;20(11):2404-8
pubmed: 27338067
JAMA. 2021 Mar 2;325(9):855-864
pubmed: 33523115
Front Pediatr. 2020 Aug 25;8:493
pubmed: 32984207
Sci Rep. 2019 Jan 23;9(1):328
pubmed: 30674924
Brain Behav Immun. 2020 Jul;87:703-714
pubmed: 32156515
Life Sci Alliance. 2021 Jul 28;4(9):
pubmed: 34321327
Exp Ther Med. 2021 Sep;22(3):1022
pubmed: 34373708
Zhongguo Dang Dai Er Ke Za Zhi. 2016 Oct;18(10):988-990
pubmed: 27751217
Exp Ther Med. 2021 Feb;21(2):162
pubmed: 33456529
Int J Mol Sci. 2020 Jul 29;21(15):
pubmed: 32751323
Zhongguo Dang Dai Er Ke Za Zhi. 2016 Dec;18(12):1286-1290
pubmed: 27974124
J Inflamm Res. 2021 Sep 21;14:4809-4816
pubmed: 34584439
Pediatr Infect Dis J. 2021 Nov 1;40(11):e407-e412
pubmed: 34382611
Pediatr Rheumatol Online J. 2019 Jan 5;17(1):1
pubmed: 30611297
Front Immunol. 2020 May 19;11:973
pubmed: 32508840
Medicina (Kaunas). 2021 Dec 20;57(12):
pubmed: 34946330
J Clin Lab Anal. 2019 Jun;33(5):e22874
pubmed: 30843267